Key Segmentation
By Product Type
-
Independent Controls
-
Instrument-Specific Controls
By Analyte Type
-
Single-Analyte
-
Multi-Analyte
By Application
-
Infectious Disease Diagnosis
-
Oncology Testing
-
Genetic Testing
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players in the Molecular Quality Controls Market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., LGC Limited (SeraCare), QIAGEN N.V., and Microbiologics, Inc., among others.
Key opportunities lie in developing specialized quality control materials for expanding companion diagnostic testing, and in establishing early distribution relationships in fast-growing emerging market laboratory accreditation programs.
The rapid global expansion of molecular diagnostics testing, combined with tightening laboratory accreditation and regulatory requirements for diagnostic accuracy, is the major growth factor.
By Product Type, the Independent Controls segment dominated the Molecular Quality Controls Market with approximately 57.52% share in 2025.
North America dominated the Molecular Quality Controls Market with approximately 41.85% share in 2025, supported by an extensive accredited clinical laboratory network and stringent regulatory requirements.
